Risk factors for nonelective 30-day readmission in pediatric assault victims

Jessica L Buicko1, Joshua Parreco1, Brent A Willobee1

  • 1Division of Pediatric Surgery, DeWitt-Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA.

Insights

Pediatric assault victims have a 3.23% readmission rate, with repeated assault being a common reason. Key risk factors for readmission include prolonged hospital stay, psychoses, and weight loss.

Area of Science:

  • Trauma Surgery
  • Pediatric Surgery
  • Public Health

Background:

  • Hospital readmissions in trauma patients are linked to increased morbidity and healthcare costs.
  • Early hospital readmission data in pediatric trauma patients is scarce.
  • Readmission rates are increasingly used as hospital quality indicators.

Purpose of the Study:

  • To determine national readmission rates in pediatric assault victims.
  • To identify common readmission diagnoses in this population.
  • To recognize risk factors for readmission.

Main Methods:

  • Utilized the 2013 Nationwide Readmission Database (NRD).
  • Included pediatric patients (<18 years) with non-elective assault admissions.
  • Employed multivariate logistic regression to identify 30-day readmission risk factors.

Main Results:

  • A total of 4050 pediatric assault victims were analyzed; 3.23% were readmitted within 30 days.
  • Readmission for repeated assault occurred in 24.22% of readmitted patients.
  • Significant risk factors for readmission included length of stay >7 days, psychoses, and weight loss.

Conclusions:

  • Readmission among pediatric assault victims poses a substantial resource burden.
  • Identifying risk factors like psychoses, weight loss, and prolonged hospitalization can improve patient outcomes.
  • Enhanced discharge planning and support are crucial for reducing readmissions and costs.
Abstract

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
61
Bullying02:04

Bullying

A modern form of aggression is bullying. As you learn in your study of child development, socializing and playing with other children is beneficial for children’s psychological development. However, as you may have experienced as a child, not all play behavior has positive outcomes. Some children are aggressive and want to play roughly. Other children are selfish and do not want to share toys. One form of negative social interactions among children that has become a national concern is...
8.9K
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
411